Adam R. Dolan Quoted in "State Prosecution of Medical Marijuana Execs Highlights Risks to Avoid, Lawyers Say," National Law Journal March 8, 2018

“You’re not going to see a lot of interstate commerce at this point because of the federal government’s stance" on medical and recreational marijuana, Goldberg Segalla's Adam R. Dolan told The National Law Journal.

Adam, an associate in the firm's White Plains office, commented on pending felony charges in Minnesota against two former executives of the medical marijuana dispensary Vireo Health, LLC, for transferring medical cannabis across state lines. Since U.S. Attorney General Jeff Sessions' recision of the Obama-era "Cole memo," which directed federal prosecutors to focus on drug cartels and and cross-border trafficking rather than above-the-board marijuana operations in compliance with their respective state regulatory schemes, industry executives, investors, and attorneys have questioned whether the Department of Justice will actively pursue particular states or dispensaries, Adam told the Journal. He noted, though, that the recently renewed Rohrbacher-Blumenauer Amendment temporarily prohibits the Department from spending any federal funds on prosecuting marijuana-related activities allowed under state law.

A tested litigator with a multifaceted practice and previous experience as a Bronx County Assistant District Attorney, Adam has become a go-to authority on evolving issues related to marijuana legalization. He was last quoted on the subject in New York Law Journal.

Read the article: